Copper for Antioxidant Defense

Copper has a Janus-faced relationship with oxidative stress. When properly chaperoned to its enzyme targets, copper is the catalytic atom at the active site of the two great antioxidant cuproenzymes — Cu/Zn superoxide dismutase (SOD1), which converts superoxide radical to hydrogen peroxide, and ceruloplasmin, which removes free Fe²+ before it can drive Fenton-chemistry hydroxyl-radical formation. But when copper is free in the cytosol — unchaperoned, in excess, or released from damaged tissue — the same redox chemistry that makes it useful as an enzyme cofactor makes it dangerous as a one-electron oxidant, generating hydroxyl radicals through both Fenton-type reactions and Haber-Weiss cycling. The Wilson disease genetic disorder, where ATP7B mutation prevents biliary copper excretion and copper accumulates pathologically in liver and brain, demonstrates the toxic-pro-oxidant face of copper. Both faces are real, both are mediated by the same fundamental redox chemistry, and the entire framework of human copper handling is built around keeping copper bound to chaperones and target enzymes rather than free in solution. This page walks through the two great antioxidant cuproenzymes, the chaperone system that delivers copper safely, the Wilson disease syndrome that illustrates copper overload, and the emerging "cuproptosis" cell-death pathway.

Table of Contents

  1. The Janus Face of Copper Redox Chemistry
  2. Cu/Zn Superoxide Dismutase (SOD1) — the Cytosolic First Line
  3. Extracellular SOD (SOD3) and SOD2 (Mn-SOD in Mitochondria)
  4. Ceruloplasmin as Antioxidant Beyond Ferroxidase
  5. The Copper Chaperone System (CCS, COX17, ATOX1)
  6. Free Copper, Fenton Chemistry, and Hydroxyl Radicals
  7. Wilson Disease — the Copper Overload Syndrome
  8. Cuproptosis — a Newly Defined Cell Death Pathway
  9. SOD1 Mutations and Familial ALS
  10. Clinical Applications and Cautions
  11. Key Research Papers
  12. Connections

The Janus Face of Copper Redox Chemistry

Copper's biological utility derives from its ability to cycle between two oxidation states — Cu+ (cuprous) and Cu²+ (cupric) — with a redox potential that sits squarely in the middle of biologically relevant electron-transfer reactions. This makes copper an ideal catalytic atom for the electron-transfer chemistry that the cell needs to do for energy metabolism (cytochrome c oxidase), iron oxidation (ceruloplasmin and hephaestin), antioxidant defense (Cu/Zn SOD), pigmentation (tyrosinase), neurotransmitter conversion (dopamine beta-hydroxylase), and connective-tissue cross-linking (lysyl oxidase).

The same chemistry, however, makes free copper dangerous. A free Cu+ or Cu²+ ion in solution will participate in single-electron transfer reactions with hydrogen peroxide (the substrate that catalase and glutathione peroxidase normally dispose of) to generate hydroxyl radicals (.OH), the most damaging reactive oxygen species in biology. The hydroxyl radical reacts indiscriminately with anything nearby — lipid membranes, proteins, DNA — at near-diffusion-limited rates. There is no enzymatic defense against the hydroxyl radical once it forms; the only defense is preventing its formation by sequestering the catalytic metals (iron and copper) away from hydrogen peroxide.

The cell solves this problem by binding essentially all copper to proteins. Free copper concentrations inside the cell are estimated at less than one copper atom per cell — effectively zero. The copper that enters the cell through the CTR1 transporter is immediately handed off to a copper chaperone protein, which delivers it directly to its target enzyme. Excess copper is bound by metallothionein, a small cysteine-rich protein that can hold up to 12 copper atoms in tight thiolate coordination. The chaperone-and-metallothionein system means that copper is essentially never free in the cytosol of a healthy cell.

When this system fails — from genetic loss of the ATP7B copper-exporting ATPase in Wilson disease, from acute tissue injury that releases copper from damaged cells, or from chronic inflammation that overwhelms the chaperone capacity — copper becomes pro-oxidant, and the same redox chemistry that makes copper essential becomes toxic.

Back to Table of Contents

Cu/Zn Superoxide Dismutase (SOD1) — the Cytosolic First Line

Cu/Zn superoxide dismutase (SOD1) is the cytosolic antioxidant enzyme that catalyzes the dismutation of superoxide radical (O&sub2;&sup-;) to hydrogen peroxide (H&sub2;O&sub2;) and molecular oxygen. The reaction is:

2 O&sub2;&sup-; + 2 H+ → H&sub2;O&sub2; + O&sub2;

SOD1 is a homodimer of 32 kilodaltons total, with each subunit containing one catalytic copper atom (which cycles between Cu²+ and Cu+ during catalysis) and one structural zinc atom (which stabilizes the active-site geometry). It is one of the most abundant proteins in the cell, present at micromolar concentrations in the cytosol, the inner mitochondrial intermembrane space, and the nucleus.

The substrate — superoxide — is generated continuously as a byproduct of mitochondrial respiration (estimated 1–3% of all oxygen consumed by the mitochondrial electron transport chain "leaks" to form superoxide), and at much higher rates during inflammation (the NADPH oxidase of activated neutrophils generates large bursts of superoxide as part of pathogen killing). Without SOD1, superoxide accumulates, leading to two problems:

  1. Direct oxidative damage — superoxide oxidizes iron-sulfur cluster proteins (aconitase, succinate dehydrogenase) and releases their iron, which then participates in Fenton-chemistry hydroxyl-radical generation
  2. Reaction with nitric oxide — superoxide reacts with NO at near-diffusion-limited rate to form peroxynitrite (ONOO&sup-;), a powerful oxidant and nitrating agent that damages tyrosine residues, lipids, and DNA

SOD1 disposes of superoxide before either of these reactions can occur. The product, hydrogen peroxide, is then disposed of by catalase (in peroxisomes) and by glutathione peroxidase (in the cytosol and mitochondria, using glutathione as the reductant).

Copper deficiency reduces SOD1 enzymatic activity because newly synthesized SOD1 polypeptide cannot be loaded with copper. The deficiency is dose-dependent — mild copper deficiency reduces SOD1 activity by 20–40%, severe deficiency by 60–80%. The clinical consequences in tissues include increased markers of oxidative damage (MDA, 4-HNE for lipid peroxidation; 8-OHdG for DNA oxidation; protein carbonyls) and accelerated tissue aging.

Back to Table of Contents

Extracellular SOD (SOD3) and SOD2 (Mn-SOD in Mitochondria)

SOD1 is one of three superoxide dismutase enzymes in human cells. The other two are SOD2 (manganese SOD, MnSOD) in the mitochondrial matrix and SOD3 (extracellular Cu/Zn SOD, EC-SOD) in the extracellular space, particularly the lung interstitium and vascular endothelium.

The clinical implication: copper deficiency reduces both cytosolic SOD1 and extracellular SOD3 activity simultaneously, with effects on tissue oxidative balance, vascular reactivity, and pulmonary defense against inhaled oxidants. Manganese deficiency (much rarer than copper deficiency) reduces SOD2, with mitochondrial dysfunction. The three SOD enzymes are complementary, not redundant, and a clinically intact antioxidant defense requires all three.

Back to Table of Contents

Ceruloplasmin as Antioxidant Beyond Ferroxidase

The ceruloplasmin ferroxidase activity that gates iron mobilization is also, indirectly, a major antioxidant function. Free Fe²+ in plasma or interstitial fluid is a potent Fenton-reaction catalyst, generating hydroxyl radicals from any hydrogen peroxide present:

Fe²+ + H&sub2;O&sub2; → Fe³+ + .OH + OH&sup-;

By rapidly oxidizing Fe²+ to Fe³+ (which is far less reactive in Fenton chemistry and which is the form that transferrin sequesters), ceruloplasmin prevents this radical-generating reaction. The ferroxidase activity is therefore both an iron-mobilization mechanism and an antioxidant mechanism.

Beyond ferroxidase, ceruloplasmin has additional antioxidant activities:

The Linus Pauling Institute and other authoritative reviews emphasize that ceruloplasmin is one of the largest antioxidant proteins in plasma by mass, and that its antioxidant role is at least as clinically important as its ferroxidase role. Aceruloplasminemia (genetic ceruloplasmin deficiency) produces tissue iron overload AND increased oxidative stress markers, consistent with the dual function.

Back to Table of Contents

The Copper Chaperone System (CCS, COX17, ATOX1)

Inside the cell, copper does not diffuse freely — it is handed from protein to protein in a chaperone-mediated relay that ensures every copper atom is bound at every moment. The major copper chaperones are:

The chaperone system is what makes copper safe. Free cytosolic copper concentrations are estimated at less than 10&sup-;¹8; molar — effectively zero free copper atoms per cell. Every copper atom is on its way from CTR1 to its chaperone to its target. This is utterly different from the "free pool" model that might be intuitive but is biologically wrong — there is no free copper pool in healthy cells.

The clinical implication: copper toxicity, whether from Wilson disease, acute copper sulfate ingestion, or industrial copper poisoning, occurs precisely when the chaperone-and-metallothionein system is saturated and free copper begins to accumulate in the cytosol.

Back to Table of Contents

Free Copper, Fenton Chemistry, and Hydroxyl Radicals

The mechanism by which free copper becomes toxic is the same Fenton chemistry described above for iron, but with copper as the catalytic metal:

Cu+ + H&sub2;O&sub2; → Cu²+ + .OH + OH&sup-;

The hydroxyl radical produced is the most damaging oxidant in biology. It reacts at near-diffusion-limited rate with whatever is nearby:

The Haber-Weiss cycle compounds the damage by allowing copper to cycle between oxidation states and continually generate hydroxyl radicals:

Cu²+ + O&sub2;&sup-; → Cu+ + O&sub2;
Cu+ + H&sub2;O&sub2; → Cu²+ + .OH + OH&sup-;

A single copper atom can therefore generate many hydroxyl radicals if both superoxide and hydrogen peroxide are available, making free copper a catalytic poison rather than a stoichiometric one. This is why even small amounts of free copper are toxic and why the chaperone system is so important.

Back to Table of Contents

Wilson Disease — the Copper Overload Syndrome

Wilson disease is the autosomal recessive disorder caused by loss-of-function mutations in ATP7B, the hepatic copper-exporting ATPase. In healthy hepatocytes, ATP7B has two functions: loading copper onto apoceruloplasmin in the trans-Golgi network for secretion into plasma, and exporting excess copper into the bile canaliculus for fecal elimination. In Wilson disease, both functions fail. Copper that enters the hepatocyte cannot leave it, and apoceruloplasmin is secreted without its copper cargo (and is rapidly degraded), so serum ceruloplasmin is low.

The clinical phenotype emerges in the second to fourth decade of life and has two major presentations:

The diagnostic criteria use a combination of low serum ceruloplasmin (<20 mg/dL), elevated 24-hour urinary copper (>100 mcg/24 h), elevated hepatic copper on liver biopsy (>250 mcg/g dry weight), Kayser-Fleischer rings on slit-lamp exam, and ATP7B genetic testing. The Leipzig scoring system (Ferenci 2003) combines these into a numerical diagnostic score.

Treatment is lifelong copper chelation with D-penicillamine (first-line, but limited by side effects), trientine (better tolerated, replacing penicillamine as first-line in many centers), or zinc (which induces intestinal metallothionein and blocks copper absorption, used for maintenance after initial chelation). The disease was uniformly fatal before chelation therapy became available in the 1950s; with early diagnosis and lifelong treatment, normal life expectancy is achievable.

Back to Table of Contents

Cuproptosis — a Newly Defined Cell Death Pathway

In 2022, Tsvetkov P et al. published a landmark paper in Science describing a new form of programmed cell death they named cuproptosis, distinct from apoptosis, necroptosis, ferroptosis, and pyroptosis. The mechanism involves copper-induced aggregation of mitochondrial proteins that are bound to lipoylated tricarboxylic acid (TCA) cycle enzymes — particularly the E2 subunit of pyruvate dehydrogenase (DLAT) and dihydrolipoamide S-succinyltransferase (DLST).

The mechanism in outline:

  1. Copper, delivered into the mitochondria, binds directly to lipoylated TCA-cycle enzyme subunits
  2. The copper-bound lipoylated proteins aggregate, forming insoluble protein clumps
  3. Iron-sulfur cluster proteins are destabilized in parallel
  4. Cellular proteotoxic stress triggers cell death

Cuproptosis is mechanistically interesting for several reasons. It explains why Wilson disease tissues develop the specific pattern of injury they do (loss of proliferating hepatocytes and basal ganglia neurons, both copper-accumulating tissues). It opens a new therapeutic avenue for cancers that are vulnerable to mitochondrial proteotoxic stress, since some tumors may be selectively vulnerable to cuproptosis-inducing copper ionophores (elesclomol is the prototype). And it confirms the broader principle that the same trace metal whose proper handling is essential for life becomes a programmed-death trigger when handling fails.

For a closely related metal-driven cell death pathway, see ferroptosis — the iron-dependent form of regulated cell death characterized by lipid peroxidation accumulation when the GPX4 selenoprotein cannot keep up with phospholipid oxidation. Ferroptosis and cuproptosis are both metal-driven programmed cell death pathways with implications for neurodegeneration and cancer therapy.

Back to Table of Contents

SOD1 Mutations and Familial ALS

A subset of familial amyotrophic lateral sclerosis (ALS, ~10–20% of familial cases, ~2% of all ALS) is caused by missense mutations in the SOD1 gene. Notably, these are gain-of-function mutations, not loss-of-function — the mutated SOD1 protein retains most or all of its superoxide-dismutating activity but acquires a toxic conformation that misfolds, aggregates, and damages motor neurons through mechanisms that include mitochondrial dysfunction, ER stress, and disruption of axonal transport.

This is a critical mechanistic distinction. SOD1-ALS is not caused by failure of antioxidant defense (the enzyme still works); it is caused by toxic gain of function from the misfolded mutant protein. Copper supplementation does not help SOD1-ALS and may worsen it by enabling more rapid maturation of the toxic mutant protein. The genetic discovery (Rosen DR et al. 1993) was nonetheless transformative for ALS research because it established that ALS could be caused by a single-gene mutation and provided the basis for transgenic mouse models of the disease.

The therapeutic implication is narrow but important: in any patient with familial ALS or sporadic ALS with copper supplement use, the copper supplement should be reviewed, and unselected high-dose copper supplementation should not be recommended as a general "antioxidant" strategy. Adequate dietary copper for SOD1 activity is desirable; supraphysiologic copper is not.

For more on ALS, see our ALS page.

Back to Table of Contents

Clinical Applications and Cautions

For related antioxidant topics, see our pages on Oxidative Stress, Vitamin E, Vitamin C, and the master antioxidant Glutathione.

Back to Table of Contents

Key Research Papers

  1. McCord JM, Fridovich I (1969). Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). Journal of Biological Chemistry. — PubMed
  2. Rosen DR et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. — PubMed
  3. Culotta VC et al. (1997). The copper chaperone for superoxide dismutase. Journal of Biological Chemistry. — PubMed
  4. Tsvetkov P et al. (2022). Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. — PubMed
  5. Brewer GJ (2010). Copper toxicity in the general population. Clinical Neurophysiology. — PubMed
  6. Ferenci P et al. (2003). Diagnosis and phenotypic classification of Wilson disease. Liver International. — PubMed
  7. Halliwell B, Gutteridge JM (1990). Role of free radicals and catalytic metal ions in human disease: an overview. Methods in Enzymology. — PubMed
  8. Linder MC (2001). Copper and genomic stability in mammals. Mutation Research. — PubMed
  9. Squitti R et al. (2014). Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease. Journal of Alzheimer's Disease. — PubMed
  10. Valko M et al. (2005). Metals, toxicity and oxidative stress. Current Medicinal Chemistry. — PubMed
  11. Brewer GJ, Yuzbasiyan-Gurkan V (1992). Wilson disease. Medicine (Baltimore). — PubMed
  12. Folwaczny C et al. (1997). Antioxidant and prooxidant properties of ceruloplasmin and transferrin in liver disease. Hepatology. — PubMed

PubMed Topic Searches

Back to Table of Contents

Connections

Back to Table of Contents